Professor Lisa Stehno-Bittel

Likarda, LLC

Automated Pipetting Solutions Enhance Assay Development for Early Stage Drug Discovery

Likarda LLC, a contract research organization, works with clients at the early stages of drug development and discovery.  Dr Lisa Stehno-Bittel, President & Co-founder of Likarda, discusses how the company develops 3D cell clusters, which are indicative of native tissues in the body, for use in cell-based assays. Hear from research scientist Stephen Harrington PhD, Likarda’s Director of Production, how the team has utilized automation to increase throughput and reproducibility, most recently employing the Integra Assist to bridge the gap between manual bench work and complete automation.



LIKE 1
Professor Lisa Stehno-Bittel
Screening Drug discovery

Professor Lisa Stehno-Bittel

Biography

Lisa Stehno-Bittel, PT,... More
Follow Lisa

Professor Lisa Stehno-Bittel

Likarda, LLC

Lisa Stehno-Bittel, PT, Ph.D., serves as director of a medical imaging course for physical therapy and audiology students as well as for an administration course for physical therapists at the University of Kansas Medical Center. In 2012, Lisa licensed her laboratory patents from the University of Kansas and co-founded the biotech company, Likarda, which was named one of the 50 most promising start-ups in the world during Global Entrepreneur week. The patents had applications in drug screening for efficacy and toxicity, as well as the ability to transform cell-based therapeutics. Since then Likarda has grown to provide drug discovery and product testing services – as well as produce cell-based therapies – for companion animals.